Envestnet Asset Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-107,425
Closed -$26.4M 4115
2022
Q3
$26.4M Buy
107,425
+1,564
+1% +$384K 0.02% 649
2022
Q2
$26.2M Buy
105,861
+4,106
+4% +$1.02M 0.01% 661
2022
Q1
$33.7M Buy
101,755
+56,410
+124% +$18.7M 0.02% 628
2021
Q4
$16.3M Buy
45,345
+7,194
+19% +$2.58M 0.01% 935
2021
Q3
$12.4M Buy
38,151
+6,268
+20% +$2.04M 0.01% 1020
2021
Q2
$9.95M Buy
31,883
+4,578
+17% +$1.43M 0.01% 1137
2021
Q1
$8.7M Buy
27,305
+4,487
+20% +$1.43M 0.01% 1122
2020
Q4
$7.4M Buy
22,818
+5,857
+35% +$1.9M 0.01% 1077
2020
Q3
$4.7M Buy
16,961
+8,095
+91% +$2.24M ﹤0.01% 1206
2020
Q2
$2.14M Buy
8,866
+2,875
+48% +$695K ﹤0.01% 1533
2020
Q1
$870K Buy
5,991
+896
+18% +$130K ﹤0.01% 1896
2019
Q4
$869K Sell
5,095
-7,321
-59% -$1.25M ﹤0.01% 2115
2019
Q3
$2.21M Buy
12,416
+2,213
+22% +$394K ﹤0.01% 1495
2019
Q2
$2.66M Sell
10,203
-160
-2% -$41.7K ﹤0.01% 1383
2019
Q1
$2.96M Sell
10,363
-6,278
-38% -$1.79M ﹤0.01% 1275
2018
Q4
$5.41M Buy
16,641
+16,051
+2,721% +$5.22M 0.01% 848
2018
Q3
$265K Sell
590
-1,375
-70% -$618K ﹤0.01% 1075
2018
Q2
$803K Sell
1,965
-20
-1% -$8.17K ﹤0.01% 1135
2018
Q1
$606K Sell
1,985
-271
-12% -$82.7K ﹤0.01% 1133
2017
Q4
$422K Sell
2,256
-119
-5% -$22.3K ﹤0.01% 1560
2017
Q3
$398K Buy
2,375
+28
+1% +$4.69K ﹤0.01% 1569
2017
Q2
$335K Sell
2,347
-874
-27% -$125K ﹤0.01% 1679
2017
Q1
$404K Buy
3,221
+558
+21% +$70K ﹤0.01% 1632
2016
Q4
$302K Buy
2,663
+60
+2% +$6.8K ﹤0.01% 1717
2016
Q3
$335K Sell
2,603
-2,543
-49% -$327K ﹤0.01% 1777
2016
Q2
$562K Sell
5,146
-395
-7% -$43.1K ﹤0.01% 1594
2016
Q1
$525K Sell
5,541
-222
-4% -$21K ﹤0.01% 1614
2015
Q4
$520K Buy
5,763
+356
+7% +$32.1K ﹤0.01% 1571
2015
Q3
$502K Sell
5,407
-447
-8% -$41.5K ﹤0.01% 1598
2015
Q2
$385K Sell
5,854
-439
-7% -$28.9K ﹤0.01% 1841
2015
Q1
$450K Buy
+6,293
New +$450K ﹤0.01% 1600